Invivyd, Inc. (IVVD) analyst actions
Rating and price-target actions on IVVD in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the IVVD overview →
3 measured IVVD analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome | Press release | -6.13% | -5.03% | |
| Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID | Press release | -1.72% | -3.45% | |
| Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability | Press release | -0.29% | +138.63% |
Keep exploring
More IVVD: earnings → · SEC filings → · IVVD overview →